[1]杨夏,管志伟,范淑华,等.名中医史纪基于毒损肺络理论辨治儿童重症肺炎支原体肺炎经验[J].陕西中医,2026,(4):539-543.[doi:DOI:10.3969/j.issn.1000-7369.2026.04.021]
　YANG Xia,GUAN Zhiwei,FAN Shuhua,et al.Professor SHI Ji’s experience in diagnosing and treating severe mycoplasma pneumoniae pneumonia in children from the perspective of toxin damaging lung collaterals[J].,2026,(4):539-543.[doi:DOI:10.3969/j.issn.1000-7369.2026.04.021]
点击复制

名中医史纪基于毒损肺络理论辨治儿童重症肺炎支原体肺炎经验

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2026年4期
页码:
539-543
栏目:
名中医经验
出版日期:
2026-04-05

文章信息/Info

Title:
Professor SHI Ji’s experience in diagnosing and treating severe mycoplasma pneumoniae pneumonia in children from the perspective of toxin damaging lung collaterals
作者:
杨夏1; 2; 管志伟1; 2; 范淑华1; 2; 赵君琪1; 2; 毋颖慧1; 2; 史纪1; 2
（1.河南中医药大学第一附属医院儿科医院，河南 郑州 450000；2.河南中医药大学儿科医学院，河南 郑州 450046）
Author(s):
YANG Xia1; 2; GUAN Zhiwei1; 2; FAN Shuhua1; 2; ZHAO Junqi1; 2; WU Yinghui1; 2; SHI Ji1; 2
(1.Pediatric Hospital,the First Affiliated Hospital of Henan University of Chinese Medicine，Zhengzhou 450000,China;2.Pediatric Medical College,Henan University of Chinese Medicine，Zhengzhou 450046,China)
关键词:
肺炎支原体肺炎; 温毒; 肺络; 性味合化; 苇茎清肺汤
Keywords:
Mycoplasma pneumoniae pneumonia; Warm toxin; Lung collaterals; Flavor and property compatibility; Weijing Qingfei decoction
分类号:
R 272
DOI:
DOI:10.3969/j.issn.1000-7369.2026.04.021
文献标志码:
A
摘要:
史纪教授纵览温病学医籍，通过病机溯源，提出肺炎支原体属于温邪范畴。基于“温邪则热变”“温毒-肺络”理论归纳出儿童重症肺炎支原体肺炎（SMPP）核心病机为温毒伤络、痰瘀互结，依据“察舌验苔”洞悉“扭转截断点”，并据此分为苗期、极期、恢复期，主张苗期疏散先行，辅以解毒通络，极期解毒为主，重以活血通络，恢复期解余邪，佐以养阴通络，以苇茎清肺汤为基础方，结合“性味合化”理论，分期加减论治。史纪教授从毒损肺络辨治儿童SMPP，理论依据充实可靠，临证具有较好的临床疗效，为儿童SMPP诊治提供理论依据和临床借鉴。
Abstract:
After extensively reviewing the medical literature on warm diseases and tracing their pathogenesis,SHI Ji proposed that Mycoplasma pneumoniae (MP) falls under the category of warm pathogens.Based on the theory of “warm pathogens leading to heat transformation” and “warm toxin-lung collaterals”,he summarized the core pathogenesis of severe Mycoplasma pneumoniae pneumonia (SMPP) in children as warm toxin damaging collaterals and phlegm-blood stasis intermingling.By observing the tongue and coating,he identified the “critical interception point” and divided the disease into three stages:initial,peak,and recovery.He advocated for early dispersion in the initial stage,supplemented by detoxification and collateral unblocking.Prioritized detoxification in the peak stage,with emphasis on activating blood circulation and unblocking collaterals.And focused on resolving residual pathogens in the recovery stage,assisted by nourishing Yin and unblocking collaterals.Using Weijing Qingfei decoction as the foundational prescription.By combining the “theory of flavor and property compatibility”,he tailored treatments according to disease stages.Professor SHI Ji’s approach to the diagnosis and treatment of pediatric SMPP from the perspective of toxin damage to lung collaterals is theoretically robust and clinically effective,providing a theoretical basis and clinical reference for SMPP management in children.

参考文献/References:

[1]SONDERGAARD M J,FRIIS M B,HANSEN D S,et al.Clinical manifestations in infants and children with Mycoplasma pneumoniae infection[J].PLoS One,2018,13(4):e0195288.
[2]BIAGI C,CAVALLO A,ROCCA A,et al.Pulmonary and extrapulmonary manifestations in hospitalized children with mycoplasma Pneumoniae infection[J].Microorganisms,2021,9(12):2553.
[3]CURTISS P,MELNICK L,SICCO K L,et al.Mycoplasma pneumoniae,more than a lung disease[J].Dermatol Online J,2018,24(6):13030.
[4]ZHAI Y Y,WU S Z,YANG Y,et al.An analysis of 20 clinical cases of refractory mycoplasma pneumonia in children[J].Ann Palliat Med,2020,9(5):2592-2599.
[5]YAN C,XUE G,ZHAO H,et al.Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children[J].Pediatr Pulmonol,2019,54(7):1012-1021.
[6]吴蕾,方圆,吴朔,等.某三甲医院住院肺炎患者下呼吸道病原体流行病学特征分析[J].陕西医学杂志,2021,50(10):1299-1302.
[7]管志伟,赵琼,丁樱,等.基于“温邪则热变最速”理论的儿童肺炎支原体肺炎病因病机探析[J].时珍国医国药,2022,33(1):182-184.
[8]管志伟,赵琼,丁樱,等.史纪教授从“温邪则热变最速”论治儿童肺炎支原体肺炎[J].亚太传统医药,2020,16(12):128-131.
[9]王雪峰,张秀英.从风温伏肺论治儿童肺炎支原体肺炎[J].世界科学技术-中医药现代化,2017,19(11):1878-1881.
[10]赵顺英,钱素云,陈志敏,等.儿童肺炎支原体肺炎诊疗指南(2023年版)[J].传染病信息,2023,36(4):291-297.
[11]吉益为则.古书医言[Ｍ].北京:人民卫生出版社,1955:22.
[12]刘瀚旻,马融.儿童肺炎支原体肺炎中西医结合诊治专家共识(2023年)[J].中国实用儿科杂志,2024,39(3):161-167,222.
[13]程燕,张赛.清肺通络法治疗儿童肺炎支原体肺炎干咳[J].河南中医,2017,37(2):257-258.
[14]茆春阳,杜燕,雷伟伟,等.基于“燥伤肺络”理论探析肺纤维化[J].陕西中医,2025,46(4):522-526.
[15]刘骅漫,贾新华,田丽,等.从“毒损肺络”理论探讨特发性肺纤维化肌成纤维细胞活化机制[J].中华中医药杂志,2022,37(2):646-649.
[16]包君丽.王孟英的舌诊特色及相关临床观察[D].哈尔滨：黑龙江中医药大学,2017.
[17]张葆青,高金金,陈鲁,等.小儿肺炎舌象特点及相关因素分析[J].山东中医药大学学报,2013,37(2):119-121.
[18]韩兆忠,郑伟然,王振中,等.从“截断扭转”理论分析热毒宁注射液的组方[J].陕西中医,2017,38(5):670-671.
[19]郑骁洋,李峰,赖敏,等.从《舌鉴辨正》探析寒热证之舌象特征[J].陕西中医,2023,44(12):1758-1761，1766.
[20]吕伟刚,张岩,宋桂华,等.千金苇茎汤加减方联合阿奇霉素治疗痰热壅肺兼血瘀证小儿肺炎支原体肺炎随机对照研究[J].中国中西医结合杂志,2021,41(10):1192-1196.
[21]曲晓红.千金苇茎汤加减方治疗小儿肺炎支原体肺炎(痰热闭肺证)的疗效及对血清因子的影响[J].中华养生保健,2024,42(1):30-33.
[22]管志伟,宋桂华,张岩,等.桑夏清肺汤分期免序贯治疗痰热壅肺型儿童支原体肺炎[J].中医学报,2018,33(6):979-985.
[23]管志伟,赵琼,丁樱,等.论五味合化理论发展源流[J].中医研究,2022,35(11):1-5.
[24]黄志英.叶天士医学全书[M].2版.北京:中国中医药出版社,2015:311-346.
[25]王孟英.温热经纬[M].北京:人民卫生出版社,2005:35.
[26]陈玲.麻杏石甘汤加减治疗小儿肺炎支原体疗效观察[J].陕西中医,2015,36(12):1586-1587.
[27]高铭凰,刘涛.温病邪留三焦证与分消走泄法探析[J].南京中医药大学学报,2022,38(1):49-52.
[28]祝盼盼,陈宝国.“通阳不在温,而在利小便”理论及其临床应用探讨[J].亚太传统医药,2022,18(11):113-116.
[29]赵妍,李海波,谷松.论“逐邪勿拘结粪”对现代疫病治疗的启示[J].中华中医药学刊,2022,40(6):104-106.
[30]陈爱玲.《医林改错》之瘀血观阐释[J].北京中医药,2016,35(11):1046-1047.
[31]张兰坤,过伟峰,肖婧,等.从叶天士“络以通为用”学说谈通络药物的临床应用[J].中医杂志,2014,55(9):804-805,808.
[32]杜宇琼,张秋云,张弛,等.基于清代温病学著作的络病理论探讨[J].中国中医药图书情报杂志,2015,39(6):45-48.
[33]李刘坤.吴鞠通医学全书[M].2版.北京:中国中医药出版社,2015:19,108.
[34]杨璇.伤寒瘟疫条辨[M].北京:中国医药科技出版社,2011:108.
[35]WANG Y S,ZHOU Y L,BAI G N,et al.Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children[J].World J Pediatr,2024,20(9):901-914.
[36]李冲.明清温病医家治疗温疫鲜药应用规律研究[D].济南：山东中医药大学,2024.

相似文献/References:

[1]贺 辉,刘正艳,梁丽娜,等.宣肺清毒汤治疗小儿支原体肺炎疗效及对患者血清炎性因子表达水平的研究[J].陕西中医,2019,(5):627.
　HE Hui,LIU Zhengyan,LIANG Lina,et al.Effect of Xuanfei Qingdu decoction on children of mycoplasma pneumonia and its influence on expression level of serum inflammatory factors[J].,2019,(4):627.
[2]赵珍珍,史艳平,邱 锐,等.清热活血方联合阿奇霉素治疗儿童肺炎支原体肺炎临床研究[J].陕西中医,2021,(5):616.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.018]
　ZHAO Zhenzhen,SHI Yanping,QIU Rui,et al.Effect of Qingre Huoxue decoction with Azithromycin on mycoplasma pneumoniae pneumonia in children[J].,2021,(4):616.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.018]
[3]刘 静,史艳平,赵珍珍,等.清肺疏络饮对肺炎支原体肺炎小鼠治疗机制研究[J].陕西中医,2023,(3):290.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.004]
　LIU Jing,SHI Yanping,ZHAO Zhenzhen,et al.Therapeutic mechanism study on Qingfei Shuluoyin on mycoplasma pneumoniae pneumonia in mice[J].,2023,(4):290.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.004]

备注/Memo

备注/Memo:
国家自然科学基金青年基金资助项目（82205190)；河南省中医药科学研究专项（2017ZY2096，2022ZY2006，2022JDZX030）
更新日期/Last Update: 2026-04-05